Fig. 8: Galunisertib reduces the expression of stemness-related genes in ex vivo HCC patients’ samples. | Cell Death & Disease

Fig. 8: Galunisertib reduces the expression of stemness-related genes in ex vivo HCC patients’ samples.

From: Galunisertib suppresses the staminal phenotype in hepatocellular carcinoma by modulating CD44 expression

Fig. 8

a Relative expression of TGFβ1 analyzed by qRT-PCR following treatment with galunisertib in ex vivo tumor samples from HCC patients. b Relative expression of CD44 and THY1 analyzed by qRT-PCR. Mean ± SEM (number of patients = 24, each experiment technically performed in triplicate). *P < 0.05; **P < 0.001

Back to article page